At the same time, the low concentration group (<0.08 mg/dL) was used as the control group, the higher CRP concentration group (>0.46 mg/dL) was associated with higher all-cause mortality (HR = 1.62, 95%CI = 1.34–1.96, P < 0.001) and cancer mortality (HR = 1.62, 95%CI = 1.15–2.28, P = 0.006). This evidence concerns the gene CRP and cancer.